ArticlePloS one2025
Ocular motor cranial neuropathy and risk of thyroid cancer: A Korean population-based study.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study investigates whether ocular motor cranial neuropathy (OMCN) can predict the onset of thyroid cancer given its association with common cardiovascular risk factors including obesity, diabetes mellitus (DM), hypertension, and dyslipidemia. We conducted a retrospective, nationwide, population-based cohort study utilizing data from the Korean National Health Insurance Service. Individuals comprised those aged ≥ 20 years diagnosed with OMCN between 2010 and 2017. Exclusions were based on pre-existing conditions, inability to match controls, or incomplete data. The study involved 118,686 participants, with 19,781 in the OMCN group and 98,905 controls, matched for age and sex. Patients with OMCN showed a significantly higher risk of developing thyroid cancer (hazard ratio [HR] = 1.392 [95% confidence interval, 1.075-1.802]) compared to controls after adjusting for potential confounding factors. This association was more pronounced in participants with DM and women (HR = 2.288 in DM vs. HR = 1.209 in non-DM, p = 0.0450; HR = 1.677 in females vs. HR = 0.824 in males, p = 0.0246). The findings suggest OMCN as a potential early predictor of thyroid cancer risk, particularly in diabetic and female patients. Further research is needed to explore the underlying mechanisms linking cardiovascular risk factors to the relationship between OMCN and thyroid cancer. Proactive management of these risk factors in OMCN patients may contribute to thyroid cancer prevention.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.